Literature DB >> 20429995

Evaluation of a risk assessment questionnaire to assist hepatitis C screening in the general population.

F Zuure1, U Davidovich, G Kok, A C Depla, C Hoebe, A van den Hoek, P L Jansen, P van Leeuwen-Gilbert, C J Weegink, R A Coutinho, M Prins.   

Abstract

Many individuals with hepatitis C virus (HCV) infection are undiagnosed. This study evaluates a risk assessment questionnaire, developed for use online to target blood-screening for HCV. Two hundred and eighty-nine patients with known HCV status completed a written questionnaire on prominent HCV risk factors. Questionnaires generated advice to seek testing if at least one risk factor was reported. Agreement of the testing advice with the HCV status of respondents was evaluated. Subsequently, we validated our questionnaire among 985 patients of an outpatient clinic for sexually transmitted infections. The post-test-probability-of-disease (PTPD) and diagnostic gain (PTPD minus prior probability of disease) were calculated. The questionnaire's sensitivity and specificity were 84.6% and 63.8%, respectively, and higher in the STI clinic patients. The PTPD of positive testing advice was 72.5% given HCV prevalence of 53.0%, yielding a diagnostic gain of 19.5%. Applying the estimated prevalence in the general Dutch population (0.1-0.4%), and the anticipated prevalence in the online project (1.0-6.0%), yielded diagnostic gains of 0.13-0.53% and 1.3-7.0%, respectively. We conclude that our questionnaire succeeded in selecting at-risk individuals as its testing advice agreed well with the HCV status. We suggest that the questionnaire be used online as a selection tool for HCV blood-screening in the general population.

Entities:  

Mesh:

Year:  2010        PMID: 20429995

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  9 in total

1.  Diagnostics: a testing journey.

Authors:  Sarah DeWeerdt
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

2.  Risk factors for HCV transmission in HIV-positive men who have sex with men in México.

Authors:  José Antonio Mata-Marín; Armando Abraham de Pablos-Leal; Stefan Mauss; Carla Ileana Arroyo-Anduiza; Mara Soraya Rodríguez-Evaristo; Luis Antonio Uribe-Noguéz; María de Los Ángeles Berrospe-Silva; Juan Carlos Lara-Castañeda; Edgar Pérez-Barragán; Jesús Gaytán-Martínez
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

3.  An Easy-to-Implement Risk Score for Targeted Hepatitis C Virus Testing in the General Population.

Authors:  Javier Martínez-Sanz; María Jesús Vivancos-Gallego; Borja Manuel Fernández-Felix; Alfonso Muriel; Pilar Pérez-Elías; Almudena Uranga; Beatriz Romero; Juan Carlos Galán; Santiago Moreno; María Jesús Pérez-Elías
Journal:  Microbiol Spectr       Date:  2022-03-31

4.  Prevalence and knowledge of hepatitis C in a middle-aged population, Dunedin, New Zealand.

Authors:  Jane Vermunt; Margaret Fraser; Peter Herbison; Anna Wiles; Martin Schlup; Michael Schultz
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

5.  Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.

Authors:  Engy Mohamed El-Ghitany; Azza Galal Farghaly; Shehata Farag; Ekram Wassim Abd El-Wahab
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

6.  Does the Strategy of Risk Group Testing for Hepatitis C Hit the Target?

Authors:  Mirjana R Jovanovic; Aleksandar Miljatovic; Laslo Puskas; Slobodan Kapor; Dijana L Puskas
Journal:  Front Pharmacol       Date:  2017-06-30       Impact factor: 5.810

7.  Development and validation of the HCV-MOSAIC risk score to assist testing for acute hepatitis C virus (HCV) infection in HIV-infected men who have sex with men (MSM).

Authors:  Astrid M Newsum; Ineke G Stolte; Jan Tm van der Meer; Janke Schinkel; Marc van der Valk; Joost W Vanhommerig; Anne Buvé; Mark Danta; Arjan Hogewoning; Maria Prins
Journal:  Euro Surveill       Date:  2017-05-25

8.  Performance and modification of EGCRISC among hepatitis C virus high-risk groups.

Authors:  E M El-Ghitany; Y M Alkassabany; A G Farghaly
Journal:  Epidemiol Infect       Date:  2020-02-14       Impact factor: 2.451

Review 9.  Who to Test for Hepatitis C Virus in the Middle East and North Africa?: Pooled Analyses of 2,500 Prevalence Measures, Including 49 Million Tests.

Authors:  Hiam Chemaitelly; Sarwat Mahmud; Silva P Kouyoumjian; Zaina Al-Kanaani; Joumana G Hermez; Laith J Abu-Raddad
Journal:  Hepatol Commun       Date:  2019-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.